alexa
Reach Us +1-845-458-6882

GET THE APP

Joseph A Califano | OMICS International
ISSN: 2161-119X

Otolaryngology: Open Access
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences

7th European Otolaryngology-ENT Surgery Conference

Vienna, Austria
Google scholar citation report
Citations : 560

Otolaryngology: Open Access received 560 citations as per google scholar report

Otolaryngology: Open Access peer review process verified at publons
Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • Geneva Foundation for Medical Education and Research
Share This Page

Joseph A Califano

Department of Otolaryngology, Head and Neck Surgery, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA

Biography

Joseph Califano, MD, is an internationally recognized physician scientist who has translated multiple discoveries from his own laboratory into the clinic, including detection of HPV-related and other head and neck cancers. Dr. Califano is Professor of Surgery in the Division of Otolaryngology-Head and Neck Surgery, Department of Surgery as well as Director, Gleiberman Head and Neck Cancer Center, and serves as Physician in Chief for Moores Cancer Center at UC San Diego Health. His major focus is the clinical practice of head and neck surgical oncology and the integration of basic, molecular biologic research in that practice.
Publications

Timing of Restaging PET/CT and Neck Dissection after Chemoradiation for Advanced Head and Neck Squamous Cell Carcinoma

Background: Concomitant chemoradiation therapy (CRT) is widely accepted as a primary treatment of advanced head and neck squamous cell carcinoma (HNSCC). However, controversy exists regarding the treatment of patients with no clinically evident nodal disease after CRT. PET/CT imaging has therefore become increasingly popular to aid in the selection... Read More»

Marietta Tan, Carole Fakhry, Katherine Fan, David Zaboli, Geoffrey Neuner, Eva S Zinreich, Marshall A Levine, Mei Tang, Ray G Blanco, John R Saunders, Joseph A Califano, Milton J Dance and Patrick K Ha

Research Article: Otolaryngology 2013, 3: 128

DOI: 10.4172/2161-119X.1000128

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article

Top